Latest Bacillus Calmette-Guérin Stories
- Assign-bTB Designed to Differentiate TB-Infected Animals from Vaccinated Ones PALMERSTON NORTH, New Zealand, Feb.
HILDEN, Germany and BEIJING, February 11, 2015 /PRNewswire/ -- - China's first population-based study of latent TB infection, published in The
HILDEN, Germany and BARCELONA, Spain, October 28, 2014 /PRNewswire/ -- - New WHO guidelines launched for prevention include screening and treating
MONTREAL, Oct. 10, 2014 /PRNewswire/ - Bioniche Life Sciences Inc.
The vaccine used to protect against tuberculosis disease (bacillus calmette-guerin or BCG) also protects against tuberculosis infection (mycobacterium) as well as protecting against progression from infection to disease.
BELLEVILLE, ON, July 18, 2014 /PRNewswire/ - Bioniche Life Sciences Inc.
A new screening process for tuberculosis (TB) infections in Canadian prisons could mean that more than 50 per cent of those screened won't undergo unnecessary treatment due to false positives.
Aeras releases TB Crisis Tracker on World TB Day ROCKVILLE, Md., March 24, 2014 /PRNewswire/ -- The tuberculosis epidemic continues
BEIJING and HILDEN, Germany, March 20, 2014 /PRNewswire/ -- - QuantiFERON-TB, the leading modern test for accurate diagnosis of latent
A new study has found that a vaccine used to thwart tuberculosis outside the US could be used to treat multiple sclerosis (MS).
Mycobacterium bovis is a slow-growing, aerobic bacterium and the causative agent of tuberculosis in cattle. Similar to M. tuberculosis, M. bovis can jump the species barrier and cause tuberculosis in humans. It is estimated that M. bovis was responsible for more losses among farm animals than all other diseases combined in the first half of the 20th century. Infection happens after bacterium is ingested. It is generally transmitted to humans via infected milk. Actual human infections are...
- A political dynamiter.